ASCO® 2024 Insights: "Impact of Exposure on Outcomes With Enfortumab Vedotin in Patients With Locally Advanced or Metastatic Urothelial Cancer"

163 views
June 6, 2024

Chapters

Introduction & Enfortumab Vedotin Overview

00:00

Study Schema & Dose Modifications

01:26

Efficacy Across Different Doses & Trials

04:14

Dose Reduction Impact on Treatment Outcomes

07:30

Safety, Efficacy & Conclusion

09:45

Comments 0
Login to view comments. Click here to Login